Fatih Yay

3PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 13, 2025
HERC2 as a Potential Biomarker for Prognosis and Response to Bevacizumab in Ovarian Cancer: A Bioinformatics Approach.

Fatih Yay, Hasan Çağrı Yıldırım

|Jan 23, 2025
Dynamine 3 as a diagnostic and prognostic biomarker in pancreatic cancer: Implications for early detection and targeted therapy.

Fatih Yay, Hasan Çağrı Yıldırım, Fatih Kuş

Pageof 1